NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 25.8% in February

NeueHealth, Inc. (NYSE:NEUE) saw a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 9,200 shares, a decrease of 25.8% from the February 13th total of 12,400 shares. Based on an average daily volume of 38,400 shares, the short-interest ratio is presently 0.2 days. Currently, 0.3% of the company’s stock are short sold.

NeueHealth Stock Performance

NEUE stock opened at $4.71 on Tuesday. NeueHealth has a one year low of $3.79 and a one year high of $7.66. The stock has a market capitalization of $38.98 million, a PE ratio of -0.09 and a beta of 0.56. The company has a fifty day moving average of $7.21 and a 200-day moving average of $6.01.

Insider Buying and Selling at NeueHealth

In other news, CEO George Lawrence Mikan III sold 12,440 shares of the company’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the completion of the transaction, the chief executive officer now owns 249,454 shares in the company, valued at approximately $1,529,153.02. This represents a 4.75 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $6.74, for a total transaction of $29,979.52. Following the completion of the transaction, the chief financial officer now owns 41,592 shares of the company’s stock, valued at approximately $280,330.08. The trade was a 9.66 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 110,033 shares of company stock valued at $774,560. Insiders own 64.30% of the company’s stock.

Institutional Trading of NeueHealth

Several hedge funds have recently made changes to their positions in NEUE. Partners Group Holding AG acquired a new stake in shares of NeueHealth in the 3rd quarter worth $463,000. Northern Trust Corp increased its holdings in shares of NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares in the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of NeueHealth in the 4th quarter valued at about $76,000. Institutional investors and hedge funds own 63.88% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada decreased their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research note on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.